AgomAb Therapeutics NV American Depositary Shares (AGMB) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for AgomAb Therapeutics NV American Depositary Shares, updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
AgomAb Therapeutics NV American Depositary Shares (AGMB) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $414M. It trades at $7.96, down 5.24% today. Its overall quality score is 53 out of 100, ranked against the whole US market. 5 analysts' average target of $35.20 implies +342.2% from today's price. Kronos AI's 30-day forecast is +40.7% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $35.20 |
| Low – high | $17.00 – $60.00 |
| Analysts | 5 |
| Upside to average | +342.2% |
Kronos AI 30-day forecast
| Expected close | $11.82 (+40.7%) |
| Likely range | +30.2% … +49.8% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 50 |
| Solvency | 71 |
| Growth | 38 |
| Overall | 53 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |